These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 24803934)
1. Virulence Factors Contributing to Pathogenicity of Candida tropicalis and Its Antifungal Susceptibility Profile. Deorukhkar SC; Saini S; Mathew S Int J Microbiol; 2014; 2014():456878. PubMed ID: 24803934 [TBL] [Abstract][Full Text] [Related]
2. Virulence Factors and Antifungal Susceptibility Profile of El-Kholy MA; Helaly GF; El Ghazzawi EF; El-Sawaf G; Shawky SM J Fungi (Basel); 2021 Apr; 7(5):. PubMed ID: 33947158 [TBL] [Abstract][Full Text] [Related]
3. Molecular Epidemiology, Antifungal Susceptibility, and Virulence Evaluation of Chen J; Hu N; Xu H; Liu Q; Yu X; Zhang Y; Huang Y; Tan J; Huang X; Zeng L Front Cell Infect Microbiol; 2021; 11():721439. PubMed ID: 34604110 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of virulence factors and azole resistance mechanisms of Jahanshiri Z; Manifar S; Hatami F Iran J Microbiol; 2023 Feb; 15(1):163-173. PubMed ID: 37069909 [TBL] [Abstract][Full Text] [Related]
5. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246 [TBL] [Abstract][Full Text] [Related]
6. Candida tropicalis isolates obtained from veterinary sources show resistance to azoles and produce virulence factors. Cordeiro Rde A; de Oliveira JS; Castelo-Branco Dde S; Teixeira CE; Marques FJ; Bittencourt PV; Carvalho VL; Bandeira Tde J; Brilhante RS; Moreira JL; Pereira-Neto Wde A; Sidrim JJ; Rocha MF Med Mycol; 2015 Feb; 53(2):145-52. PubMed ID: 25550392 [TBL] [Abstract][Full Text] [Related]
7. [Investigation of the correlation between biofilm forming ability of urinary Candida isolates with the use of urinary catheters and change of antifungal susceptibility in the presence of biofilm]. Aslan H; Gülmez D Mikrobiyol Bul; 2016 Apr; 50(2):256-65. PubMed ID: 27175498 [TBL] [Abstract][Full Text] [Related]
8. Oral candidal speciation, virulence and antifungal susceptibility in type 2 diabetes mellitus. Patel PN; Sah P; Chandrashekar C; Vidyasagar S; Venkata Rao J; Tiwari M; Radhakrishnan R Diabetes Res Clin Pract; 2017 Mar; 125():10-19. PubMed ID: 28131069 [TBL] [Abstract][Full Text] [Related]
9. [Investigation of antifungal susceptibilities and some virulence factors of Candida strains isolated from blood cultures and genotyping by RAPD-PCR]. Gültekin B; Eyigör M; Tiryaki Y; Kırdar S; Aydın N Mikrobiyol Bul; 2011 Apr; 45(2):306-17. PubMed ID: 21644074 [TBL] [Abstract][Full Text] [Related]
10. Virulence and susceptibility patterns of clinical Candida spp. isolates from a tertiary hospital, Tanzania. Mushi MF; Bader O; Bii C; Groß U; Mshana SE Med Mycol; 2019 Jul; 57(5):566-572. PubMed ID: 30380077 [TBL] [Abstract][Full Text] [Related]
11. Antifungal Susceptibility in Serum and Virulence Determinants of Candida Bloodstream Isolates from Hong Kong. Seneviratne CJ; Rajan S; Wong SS; Tsang DN; Lai CK; Samaranayake LP; Jin L Front Microbiol; 2016; 7():216. PubMed ID: 26955369 [TBL] [Abstract][Full Text] [Related]
12. Candiduria-Study of Virulence Factors and Its Antifungal Susceptibility Pattern in Tertiary Care Hospital. Pramodhini S; Srirangaraj S; Easow JM J Lab Physicians; 2021 Sep; 13(3):231-237. PubMed ID: 34602787 [No Abstract] [Full Text] [Related]
13. Comparative analysis of proteinase, phospholipase, hydrophobicity and biofilm forming ability in Candida species isolated from clinical specimens. Dabiri S; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M J Mycol Med; 2018 Sep; 28(3):437-442. PubMed ID: 29778633 [TBL] [Abstract][Full Text] [Related]
14. Oral Candida albicans isolates from HIV-positive individuals have similar in vitro biofilm-forming ability and pathogenicity as invasive Candida isolates. Junqueira JC; Fuchs BB; Muhammed M; Coleman JJ; Suleiman JM; Vilela SF; Costa AC; Rasteiro VM; Jorge AO; Mylonakis E BMC Microbiol; 2011 Nov; 11():247. PubMed ID: 22053894 [TBL] [Abstract][Full Text] [Related]
15. Anti-fungal susceptibility and virulence factors of Candida spp. isolated from blood cultures. Sriphannam C; Nuanmuang N; Saengsawang K; Amornthipayawong D; Kummasook A J Mycol Med; 2019 Dec; 29(4):325-330. PubMed ID: 31447236 [TBL] [Abstract][Full Text] [Related]
16. Antifungal susceptibility and phenotypic virulence markers of Candida species isolated from Nepal. Subramanya SH; Baral BP; Sharan NK; Nayak N; Metok Y; Sathian B; Bairy I; Gokhale S BMC Res Notes; 2017 Nov; 10(1):543. PubMed ID: 29096684 [TBL] [Abstract][Full Text] [Related]
17. Oropharyngeal candidiasis in head and neck cancer patients in Iran: Species identification, antifungal susceptibility and pathogenic characterization. Jahanshiri Z; Manifar S; Moosa H; Asghari-Paskiabi F; Mahmoodzadeh H; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M J Mycol Med; 2018 Jun; 28(2):361-366. PubMed ID: 29602636 [TBL] [Abstract][Full Text] [Related]
18. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance]. Karabıçak N; Alem N Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336 [TBL] [Abstract][Full Text] [Related]
19. Characterization of virulence factors, antifungal resistance with ERG-11 gene among Candida species isolated from pulmonary samples. Danis Vijay D; Jayanthi S; Meenakshi N; Meharaj SHS; Sujhithra A; Perumal J Microb Pathog; 2019 Dec; 137():103750. PubMed ID: 31536801 [TBL] [Abstract][Full Text] [Related]
20. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination. Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]